Skip to main content
Brian Poligone, MD, Dermatology, Fairport, NY

BrianPoligoneMD

Dermatology Fairport, NY

Director, Rochester Skin Lymphoma Center

Dr. Poligone is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Poligone's full profile

Already have an account?

  • Office

    6800 Pittsford Palmyra Rd
    Ste 150
    Fairport, NY 14450
    Phone+1 585-364-1177
    Fax+1 585-461-3509

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Dermatology, 2004 - 2007
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 2003 - 2004
  • University of North Carolina at Chapel Hill School of Medicine
    University of North Carolina at Chapel Hill School of MedicineClass of 2003

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2008 - 2025
  • CT State Medical License
    CT State Medical License 2007 - 2008
  • American Board of Dermatology Dermatology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
  • Fellow (FAAD) American Academy of Dermatology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • HyBryte™ Expanded Treatment Results to Be Presented at the European Organisation for Research and Treatment of Cancer Conference
    HyBryte™ Expanded Treatment Results to Be Presented at the European Organisation for Research and Treatment of Cancer ConferenceOctober 7th, 2024
  • Soligenix Corporate Update Letter - Key Highlights and Upcoming Catalysts
    Soligenix Corporate Update Letter - Key Highlights and Upcoming CatalystsJanuary 10th, 2022
  • Soligenix Anticipated to Achieve Multiple Milestones in 2021
    Soligenix Anticipated to Achieve Multiple Milestones in 2021March 16th, 2021
  • Join now to see all

Grant Support

  • NF Kappa B Activity In Skin Inflammation And CarcinogenesisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2009–2011

Professional Memberships